Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 19 studies | 29% ± 13% | |
brain | 17 studies | 33% ± 17% | |
peripheral blood | 16 studies | 32% ± 16% | |
eye | 11 studies | 28% ± 9% | |
intestine | 9 studies | 31% ± 15% | |
kidney | 8 studies | 25% ± 8% | |
liver | 7 studies | 35% ± 18% | |
pancreas | 5 studies | 36% ± 22% | |
bone marrow | 5 studies | 33% ± 17% | |
uterus | 5 studies | 38% ± 18% | |
lymph node | 5 studies | 25% ± 12% | |
placenta | 4 studies | 39% ± 14% | |
prostate | 4 studies | 23% ± 9% | |
adipose | 4 studies | 22% ± 3% | |
heart | 3 studies | 22% ± 6% | |
esophagus | 3 studies | 33% ± 21% | |
thymus | 3 studies | 55% ± 19% | |
breast | 3 studies | 33% ± 6% | |
skin | 3 studies | 25% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 9531.49 | 1445 / 1445 | 100% | 103.60 | 183 / 183 |
lung | 100% | 10754.32 | 578 / 578 | 100% | 102.58 | 1155 / 1155 |
ovary | 100% | 14162.34 | 180 / 180 | 100% | 86.64 | 430 / 430 |
pancreas | 100% | 6749.15 | 328 / 328 | 100% | 93.55 | 178 / 178 |
stomach | 100% | 8717.26 | 359 / 359 | 100% | 99.84 | 286 / 286 |
uterus | 100% | 13366.43 | 170 / 170 | 100% | 143.78 | 459 / 459 |
intestine | 100% | 11017.64 | 966 / 966 | 100% | 103.45 | 526 / 527 |
skin | 100% | 12546.66 | 1809 / 1809 | 100% | 100.61 | 471 / 472 |
thymus | 100% | 10840.30 | 653 / 653 | 100% | 110.05 | 603 / 605 |
kidney | 100% | 8246.31 | 89 / 89 | 100% | 73.06 | 898 / 901 |
prostate | 100% | 10531.03 | 245 / 245 | 100% | 95.09 | 500 / 502 |
breast | 100% | 11953.61 | 459 / 459 | 100% | 107.77 | 1113 / 1118 |
brain | 99% | 6147.56 | 2628 / 2642 | 100% | 94.00 | 705 / 705 |
bladder | 100% | 10466.48 | 21 / 21 | 99% | 109.53 | 500 / 504 |
adrenal gland | 100% | 8275.06 | 258 / 258 | 99% | 76.81 | 228 / 230 |
liver | 100% | 4871.69 | 226 / 226 | 99% | 47.90 | 402 / 406 |
adipose | 100% | 10730.27 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 8905.71 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 82.86 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 164.51 | 29 / 29 |
muscle | 100% | 6036.57 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 12919.33 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 131.74 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 62.94 | 1 / 1 |
heart | 99% | 5959.64 | 849 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 9437.19 | 903 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010468 | Biological process | regulation of gene expression |
GO_2000767 | Biological process | positive regulation of cytoplasmic translation |
GO_1904355 | Biological process | positive regulation of telomere capping |
GO_0032204 | Biological process | regulation of telomere maintenance |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0051602 | Biological process | response to electrical stimulus |
GO_0006396 | Biological process | RNA processing |
GO_0071392 | Biological process | cellular response to estradiol stimulus |
GO_0001889 | Biological process | liver development |
GO_0061158 | Biological process | 3'-UTR-mediated mRNA destabilization |
GO_0071732 | Biological process | cellular response to nitric oxide |
GO_1904383 | Biological process | response to sodium phosphate |
GO_0042752 | Biological process | regulation of circadian rhythm |
GO_0006401 | Biological process | RNA catabolic process |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0070934 | Biological process | CRD-mediated mRNA stabilization |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0071230 | Biological process | cellular response to amino acid stimulus |
GO_0045727 | Biological process | positive regulation of translation |
GO_0021549 | Biological process | cerebellum development |
GO_0097167 | Biological process | circadian regulation of translation |
GO_1905663 | Biological process | positive regulation of telomerase RNA reverse transcriptase activity |
GO_1900152 | Biological process | negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
GO_1901355 | Biological process | response to rapamycin |
GO_1990828 | Biological process | hepatocyte dedifferentiation |
GO_0051592 | Biological process | response to calcium ion |
GO_1904586 | Biological process | cellular response to putrescine |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0005654 | Cellular component | nucleoplasm |
GO_0106002 | Cellular component | mCRD-mediated mRNA stability complex |
GO_0005829 | Cellular component | cytosol |
GO_0014069 | Cellular component | postsynaptic density |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003682 | Molecular function | chromatin binding |
GO_0042162 | Molecular function | telomeric DNA binding |
GO_0003680 | Molecular function | minor groove of adenine-thymine-rich DNA binding |
GO_0035925 | Molecular function | mRNA 3'-UTR AU-rich region binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0042826 | Molecular function | histone deacetylase binding |
Gene name | HNRNPD |
Protein name | Heterogeneous nuclear ribonucleoprotein D Heterogeneous nuclear ribonucleoprotein D0 (hnRNP D0) (AU-rich element RNA-binding protein 1) |
Synonyms | AUF1 HNRPD |
Description | FUNCTION: Binds with high affinity to RNA molecules that contain AU-rich elements (AREs) found within the 3'-UTR of many proto-oncogenes and cytokine mRNAs. Also binds to double- and single-stranded DNA sequences in a specific manner and functions a transcription factor. Each of the RNA-binding domains specifically can bind solely to a single-stranded non-monotonous 5'-UUAG-3' sequence and also weaker to the single-stranded 5'-TTAGGG-3' telomeric DNA repeat. Binds RNA oligonucleotides with 5'-UUAGGG-3' repeats more tightly than the telomeric single-stranded DNA 5'-TTAGGG-3' repeats. Binding of RRM1 to DNA inhibits the formation of DNA quadruplex structure which may play a role in telomere elongation. May be involved in translationally coupled mRNA turnover. Implicated with other RNA-binding proteins in the cytoplasmic deadenylation/translational and decay interplay of the FOS mRNA mediated by the major coding-region determinant of instability (mCRD) domain. May play a role in the regulation of the rhythmic expression of circadian clock core genes. Directly binds to the 3'UTR of CRY1 mRNA and induces CRY1 rhythmic translation. May also be involved in the regulation of PER2 translation. . |
Accessions | A0A994J440 D6RF44 ENST00000703968.1 ENST00000508119.6 ENST00000503822.2 [Q14103-4] ENST00000703971.1 [Q14103-2] A0A994J4B1 ENST00000703970.1 D6RAF8 Q14103 ENST00000703973.1 ENST00000503822.2 ENST00000507010.6 [Q14103-1] ENST00000352301.8 [Q14103-2] H0YA96 H0Y8G5 ENST00000313899.12 [Q14103-1] ENST00000703972.1 D6RBP9 ENST00000513584.1 ENST00000353341.8 [Q14103-3] ENST00000703969.1 ENST00000507010.6 ENST00000514671.5 ENST00000515432.1 ENST00000509263.5 ENST00000509107.1 A0A994J4R1 D6RD83 D6RBQ9 A0A994J6S0 |